Emcure Company Secretary Chetan Sharma Resigns, Effective November 24, 2025

Emcure Pharmaceuticals has announced the resignation of Company Secretary and Compliance Officer, Chetan Sharma (FCS: 8352), effective from the close of business hours on November 24, 2025. Mr. Sharma is leaving to pursue other opportunities. The company has provided the required disclosure under applicable regulations.

Change in Key Personnel

Emcure Pharmaceuticals Limited announced the resignation of Mr. Chetan Sharma from the position of Company Secretary and Compliance Officer. The resignation will take effect at the close of business hours on November 24, 2025.

Reason for Departure

According to the official statement, Mr. Sharma’s departure is due to his decision to pursue opportunities outside of the organization.

Disclosure Details

The company confirmed that all necessary disclosures, as required under the applicable regulations, have been duly provided and are available for review.

Source: BSE

Previous Article

Karur Vysya Bank Revises Marginal Cost of Funds Based Lending Rates

Next Article

Sammaan Capital Timely Interest Payment on Secured and Unsecured Debentures

Write a Comment

Leave a Comment

Your email address will not be published. Required fields are marked *